Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase

EU orphan designation number: EU/3/13/1198   
Active ingredient: Recombinant human insulin receptor monoclonal antibody-fused iduronate 2-sulfatase
Indication: Treatment of mucopolysaccharidosis type II (Hunter's syndrome)
Sponsor: Voisin Consulting S.A.R.L.
64, Avenue Pierre Grenier, 92100 Boulogne Billancourt, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
15/11/2013 Orphan designation EMA/OD/091/13 (2013)8044 of 13/11/2013
22/05/2017 Change of name and/or address of sponsor